RBP1 and head and neck squamous cell carcinoma: Based on significant differences (P-value < 0.05, FDR < 0.25), GSEA was used to identify signaling pathways associated with HNSCC between the high and low RBP1 expression groups, including 265 positive regulation pathways and 212 negative regulation pathways.